Objects
Greenop, Kathryn R., Scott, Rodney J., Ashton, Lesley J., Armstrong, Bruce K., Milne, Elizabeth, Attia, John, Bower, Carol, de Klerk, Nicholas H., Norris, Murray D., Haber, Michelle, Jamieson, Sarra E., van Bockxmeer, Frank M., Gottardo, Nicholas G.. American Association for Cancer Research; 2015. Folate pathway gene polymorphisms and risk of childhood brain tumors: results from an Australian case-control study.
Milne, Elizabeth, Royle, Jill A., Haber, Michelle, Thompson, Judith R., Fritschi, Lin, Marshall, Glenn M., Armstrong, Bruce K., Miller, Margaret, Bower, Carol, de Klerk , Nicholas H., Bailey, Helen D., van Bockxmeer, Frank, Attia, John, Scott, Rodney J., Norris, Murray D.. John Wiley & Sons; 2010. Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring.
Liu, Pei Y., Sokolowski, Nicholas, Liu, Bing, Yang, Rui H., Guo, Xiang Y., Tee, Andrew E., Itoh, Ken, Wang, Jenny, Kavallaris, Maria, Haber, Michelle, Norris, Murray D., Cheung, Belamy B., Guo, Su T., Byrne, Jennifer A., Ziegler, David S., Marshall, Glenn M., Dinger, Marcel E., Codd, Rachel, Zhang, Xu D., Liu, Tao, Siddiqi, Faraz, Atmadibrata, Bernard, Telfer, Thomas J., Sun, Yuting, Zhang, Lihong, Yu, Denise, Mccarroll, Joshua. Impact Journals LLC; 2016. The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs.
Shahbazi, Jeyran, Scarlett, Christopher J., Lock, Richard B., Liu, Tao, Norris, Murray D., Liu, Bing, Haber, Michelle, Tee, Andrew E., Carrier, Alice, Biankin, Aandrew V., London, Wendy B., Marshall, Glenn M.. Impact Journals LLC; 2014. Histone deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1.
Wong, Matthew, Sun, Yuting, Xi, Zhichao, Milazzo, Giorgio, Poulos, Rebecca C., Bartenhagen, Christoph, Bell, Jessica L., Mayoh, Chelsea, Ho, Nicholas, Tee, Andrew E., Chen, Xiaoqiong, Li, Yang, Ciaccio, Roberto, Liu, Pei Y., Jiang, Chen C., Lan, Qing, Jayatilleke, Nisitha, Cheung, Belamy B., Haber, Michelle, Norris, Murray D., Zhang, Xu D., Marshall, GM, Wang, JY, Huettelmaier, S, Fischer, M, Wong, JWH, Xu, H, Perini, G, Dong, Q, George, RE, Liu, T. Nature Publishing Group; 2019. JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma.
Milne, Elizabeth, Greenop, Kathryn R., Dawson, Somer, McCowage, Geoffrey B., de Klerk, Nicholas H., van Bockxmeer, Frank M., Armstrong, Bruce K., Scott, Rodney J., Haber, Michelle, Norris, Murray D., Attia, John, Jamieson, Sarra E., Miller, Margaret, Bower, Carol, Bailey, Helen D.. American Association for Cancer Research; 2015. Folate pathway gene polymorphisms, maternal folic acid use, and risk of childhood acute lymphoblastic leukemia.
Sutton, Rosemary, Shaw, Peter J., Revesz, Tamas, Trahair, Toby N., Dalla-Pozza, Luciano, Marshall, Glenn M., O'Brien, Tracey A., Venn, Nicola C., Law, Tamara, Dissanayake, Anuruddhika, Kilo, Tatjana, Haber, Michelle, Norris, Murray D., Fraser, Chris, Alvaro, Frank. Wiley-Blackwell; 2015. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia.